Anaxis Pharma Alternatives & Competitors
3 companies similar to Anaxis Pharma — A small molecule drug discovery biotech, focussed on necroptotic cell death and...
Companies similar to Anaxis Pharma
Synta Pharmaceuticals
Innovating patient care with advanced small molecule therapies for severe medical conditio...
VBL Therapeutics (Nasdaq:VBLT)
Engineering the future of targeted medicines, breaking barriers to develop the next genera...
Ro5
Bioactivity. De Novo Drug Discovery. ADMET. Knowledge Graph.
About Anaxis Pharma
Anaxis Pharma Analysis Anaxis Pharma is an innovative Australian biotech startup founded in 2017, specializing in small molecule drug discovery for necroptotic cell death and inflammatory diseases. The company's focus on developing novel inhibitors and modulators targeting necroptosis addresses the unmet medical needs...
Biotech, Drug Discovery, Cell Death, Necroptosis, Inflammatory Diseases, Medicinal Chemistry, Preclinical Research, Joint Venture, Partnership Funding, Hit-to-Lead Campaigns, Lead Optimization, Drug Candidate Selection, Pharma Collaboration, Clinical Advancement, Research Institute Collaboration
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Anaxis Pharma and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Anaxis Pharma on 13 Nov 2024. The 3 companies listed here were last checked between 11 Sep 2024 and 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.